Hepatitis C Elimination Among People Incarcerated in Prisons: Challenges and Recommendations for Actions within a Health Systems Framework, The Lancet, May 2021
Hepatitis C in the Correctional-Community Continuum of Care: Poor Baseline Linkage Rates and Early Improvement with Care Coordination, IDWeek 2016, December 2016
New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners, Health Affairs, October 2016
Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014, Public Health Reports, August 2016
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees, The Lancet, July 2016
Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012–2014, Public Health Reports, Schoenbachler et al, May 2016
A Three-Dimensional Action Plan to Raise the Quality of Care of US Correctional Health and Promote Alternatives to Incarceration, Venters, American Journal of Public Health, April 2016
Hepatitis C in Australian prisons: a national needs assessment, Mina et al, International Journal of Public Health, March 2016
Addressing the challenges of chronic viral infections and addiction in prisons: the PRODEPIST study, Jacomet et al, Eur J Public Health, February 2016
Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006–2012, Clinical Infectious Diseases, February 2016
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis, Clinical Infectious Diseases, January 2016
Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012, Mahowald et al, Journal of Correctional Health Care, January 2016
Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications? Darke et al, Journal of Public Health (Oxf.), December 2015
Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons, He et al, Annals of Internal Medicine, November 2015
Overdose prevention for prisoners in New York: a novel program and collaboration, Zucker et al, Harm Reduction Journal, November 2015
Vaccinations in prisons: A shot in the arm for community health, Sequera et al, Human Vaccines and Immunotherapeutics, November 2015
Persons in correctional facilities in Canada: A key population for hepatitis C prevention and control, Kouyoumdjian and McIsaac, Canadian Journal of Public Health, October 2015
Hepatitis C virus infection and prisoners: Epidemiology, Outcome and Treatment, Zampino et al, World Journal of Hepatology, September 2015
Effect of HIV Prevention and Treatment Program on HIV and HCV Transmission and HIV Mortality at an Indonesian Narcotic Prison, Nelwan et al, Southeast Asian Journal Trop Med Public Helth, September 2016
Why We Should Be Willing to Pay for Hepatitis C Treatment, Clinical Gastroenterology and Hepatology, Chhatwal et al, June 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection, Linas et al, Annals of Internal Medicine, May 2015
A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System, Journal of Urban Health, May 2015
A Comparison of Liver Disease Mortality with HIV and Overdose Mortality Among Georgia Prisoners and Releasees: A 2-Decade Cohort Study of Prisoners Incarcerated in 1991, Spaulding et al, American Journal of Public Health, May 2015
Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States, Chhatwal et al, Annals of Internal Medicine, March 2015
Survey of US Correctional Institutions for Routine HCV Testing, Beckwith et al, November 2014
HCV treatment program reduced disease burden in prison, Moorjani H., Emerg Infect Dis., 2014
Hepatitis C in European prisons: a call for an evidence-informed response, Amber Arain, Geert Robaeys, and Heino Stöver, BMS Infectious Diseases, 2014
Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities, Alvarez at al, Journal of Infection and Public Health, December 2014
SToP-C: Surveillance and Treatment of Prisoners with Chronic Hepatitis C, The Kirby Institute, New South Wales, Australia, October 2014
Sofosbuvir-based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Infections in U.S. Incarcerated Populations: A Cost-Effectiveness Analysis, Liu et al, Annals of Internal Medicine, October 2014
The Changing Burden of Hepatitis C Virus Infection in the United States: Model-based Predictions, M. Kabiri et al, Annals of Internal Medicine, August 2014
Epidemiology of Hepatitis C Virus in Pennsylvania State Prisons, 2004–2012: Limitations of 1945–1965 Birth Cohort Screening in Correctional Settings, S. Larney et al, American Journal of Public Health: Research and Practice, June 2014
Telaprevir-based Triple Therapy Effective, But Costly in Incarcerated HCV Patients, John Rice, Presented at Digestive Disease Week May 2014
Responding to Hepatitis C through the Criminal Justice System, Josiah Rich, Scott Allen, and Brie Williams, New England Journal of Medicine, May 2014
Curing Chronic Hepatitis C: The Arc of a Medical Triumph, Raymond T. Chung, and Thomas F. Baumert, April 2014
Therapy for HCV Infection - The Cost of Success, Jay H. Hoofnagle, and Averell H. Sherker, New England Journal of Medicine, April 2014
A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners, PLOS One, Yap et al, February 2014
Hepatitis C Seroprevalence Among Prison Inmates Since 2001: Still High but Declining, Public Health Reports, A Varan et al, 2014
Safety and Effectiveness of a Nurse-Led Outreach Program for Assessment and Treatment of Chronic Hepatitis C in the Custodial Setting, Clinical Infectious Diseases, Lloyd et al, 2013
Enhancing Assessment and Treatment of Hepatitis C in the Custodial Setting, Clinical Infectious Diseases, Post, Arain, and Lloyd, 2013
Incidence and Prevalence of Hepatitis C in Prisons and Other Closed Settings: Results of a Systematic Review and Meta-Analysis, S. Larney et al, Hepatology, October 2013
Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs, Grady et al, Clinical Infectious Diseases, July 2013
HCV Infected Prisoners: Should they still be considered a difficult to treat population?, F Iacomi et al, BMC Infectious Diseases, 2013
Recommendations for the Implementation of a Hepatitis C Screening Program at King County Correctional Facility, University of Washington School of Public Health, K Gilmore, 2013
HCV Treatment and SVR:The gap between clinical trials and real-world treatment aspirations, General Hospital Psychiatry, CS North et al, 2013
Hepatitis C Reinfection Among Prisoners with Sustained Virological Response After Treatment for Chronic Hepatitis C, A. Marco et al, Journal of Hepatology, July 2013
Current and Future Therapies for Hepatitis C Virus Infection, Liang and Ghany, New England Journal of Medicine, May 2013
Impact of New Therapeutics for Hepatitis C Virus Infection in Incarcerated Populations, Spaulding et al, Topics in Antiviral Medicine, February/March 2013
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users, Kim et al, Hepatology, February 2013
The Affordable Care Act: Implications for Public Safety and Corrections Populations, Phillips, The Sentencing Project, September 2012
National Survey of Hepatitis C Services in Prisons in England, Department of Health, July 2012
Screening for HCV Infection in Jails, Spaulding & Thomas, AMA, March 2012
Evaluation of a Prisoner Condom Access Pilot Program Conducted in One California State Prison Facility, Lucas et al, September 2011
Viral Hepatitis in Hawaii - Differing Perspectives, Bauman and Lusk, Hawaii Medicine Journal, April 2010
Treating Hepatitis C in the Prison Population Is Cost-Saving, Tan et al, Hepatology, 2008
Clinical Outcomes of Hepatitis C Treatment in a Prison Setting: Feasibility and Effectiveness for Challenging Treatment Populations, Smith-Rohrberg Maru et al, HIV/AIDS, October 2008
Enhancing Linkages to HIV Primary Care in Jail Settings, Spaulding, Arriola, Ramos, Evaluation and Support Center, January 2007
Promoting HCV Treatment Completion for Prison Inmates: New York State’s Hepatitis C Continuity Program, Klein et al, Public Health Reports, 2007
Old Doc, New Challenges: Correctional Medicine, Bauman, Family Medicine, 2004